These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5406971)

  • 21. Update in the treatment of schizophrenia.
    Katz I; Kac M
    Aust Fam Physician; 1993 Apr; 22(4):577-80, 584-5, 590-7. PubMed ID: 8481123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What should the general practitioner know about the treatment of chronic schizophrenia with long-acting neuroleptics?].
    Beier R; Friemert K; Vehreschild T
    Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1206-7. PubMed ID: 4791840
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinicl experience with flupenthixol in the treatment of chronic schizophrenia.
    Molcan J; Kukucová H; Koníková M
    Act Nerv Super (Praha); 1971; 13(3):180-1. PubMed ID: 5113828
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemispheric dominance in schizophrenics as determined on extrapyramidal side effects of neuroleptics].
    Pethö B; Taríska P; Pintér K; Sommer E
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jan; 30(1):23-7. PubMed ID: 643972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical testing of a new long-term neuroleptic (Fluspirilene) with special reference to the neuroleptic threshold].
    Haase HJ; Frank T; Knaack M; Lehnhardt C; Richter-Peill H
    Nervenarzt; 1968 Jun; 39(6):275-9. PubMed ID: 5712433
    [No Abstract]   [Full Text] [Related]  

  • 26. Pimozide compared with fluphenazine in schizophrenia.
    Kenway AK; Masheter HC
    Br J Clin Pract; 1971 Feb; 25(2):69-72. PubMed ID: 4927983
    [No Abstract]   [Full Text] [Related]  

  • 27. Tranquilizing effects of SKF 14336 in chronic schizophrenic patients.
    Freeman H; Oktem MR
    Curr Ther Res Clin Exp; 1966 Aug; 8(8):395-9. PubMed ID: 4958156
    [No Abstract]   [Full Text] [Related]  

  • 28. [Schizophrenia; outpatient treatment with neuroleptic agents].
    Bilderbeek WF
    Tijdschr Ziekenverpl; 1974 Jun; 27(25):568-70. PubMed ID: 4495625
    [No Abstract]   [Full Text] [Related]  

  • 29. A pilot study of SK&F 10812 in chronic schizophrenics.
    Sugerman AA; Lichtigfeld FJ
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):707-11. PubMed ID: 4953691
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of schizophrenia with neuroleptics from the pharmacologic viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(47):1690-3. PubMed ID: 5385462
    [No Abstract]   [Full Text] [Related]  

  • 31. [A clinico-statistical analysis of the results of the treatment of schizophrenic patients with an uninterrupted-progressive course with psychotropic drugs].
    Stupochenko MV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):428-31. PubMed ID: 5795730
    [No Abstract]   [Full Text] [Related]  

  • 32. [Psychiatry and the general practitioner. I. The schizophrenic as a patient of the general physician].
    Antignani P
    Minerva Psichiatr; 1989; 30(2):61-8. PubMed ID: 2674583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic evaluation of R-2498 (triperidol) in hospitalized schizophrenic patients].
    Bueno JR
    Hospital (Rio J); 1965 May; 67(5):1035-43. PubMed ID: 5294561
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychopathological side effects of psychotropic drug therapy.
    Tesarová O
    Act Nerv Super (Praha); 1972; 14(2):91-2. PubMed ID: 5040178
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term therapy of chronic schizophrenia with Tiotixen].
    Rottka EM
    Med Klin; 1968 Dec; 63(51):2078-81. PubMed ID: 5730448
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic results and complications in the use of lyogen in long-term schizophrenics].
    Kutsenok BM; Zolotnitskiĭ RI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1578-83. PubMed ID: 5490156
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic pathomorphology during the terminal stages of schizophrenia].
    Vartanian FE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):250-7. PubMed ID: 5661308
    [No Abstract]   [Full Text] [Related]  

  • 38. Two pilot studies of BC-347 in chronic schizophrenic patients.
    Simpson GM; Angus JW; Sugerman AA; Stolberg H
    J Clin Pharmacol J New Drugs; 1968; 8(3):196-9. PubMed ID: 4872084
    [No Abstract]   [Full Text] [Related]  

  • 39. Two decades of psychopharmacology and community mental health: old and new problems of the schizophrenic patient.
    Crane GE
    Trans N Y Acad Sci; 1974 Nov; 36(7):644-62. PubMed ID: 4531769
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptics and disinhibition].
    Aubrée JC; Boulenger JP; Chevalier JF; Plas J
    Encephale; 1978; 4(1):53-60. PubMed ID: 658014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.